Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Showing news for:APLLTDConsumer Services
Clear all filters
positive
CNBC TV18 - Markets 35d ago
Alembic Pharma to acquire 45% stake in Canadian venture for pharma market expansion
Alembic Pharmaceuticals enters a Canadian joint venture with a 45% stake as it looks to strengthen its global pharma footprint. Alembic Pharmaceuticals shares closed at ₹742.75 on the NSE, up ₹5.20 or 0.71%.
ALEMBICLTDAPLLTDGLOBALConsumer ServicesHealthcare
positive
ET Markets - Industry 58d ago
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate cancer treatment. The approval is for the 300 mg strength. The drug is a generic version of Nubeqa Tablets. The robust market potential for these tablets suggests promising future growth for Alembic.
ALEMBICLTDAPLLTDFELFELDVRFMNLConsumer ServicesHealthcare